5-(2,3-Dihydro-indole-1-sulfonyl)-1,3-dihydro-indol-2-one → HCID 69707065, Verbindung
Reaktionsgleichung
[N:1]1([S:10]([C:13]2[CH:14]=[C:15]3[C:19](=[CH:20][CH:21]=2)[NH:18][C:17](=[O:22])[CH2:16]3)(=[O:12])=[O:11])[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[CH2:3][CH2:2]1.[O:23]=[C:24]1[C:29]2=[CH:30][NH:31][C:32]([CH:33]=O)=[C:28]2[CH2:27][CH2:26][O:25]1>>[N:1]1([S:10]([C:13]2[CH:14]=[C:15]3[C:19](=[CH:20][CH:21]=2)[NH:18][C:17](=[O:22])[C:16]3=[CH:33][C:32]2[NH:31][CH:30]=[C:29]3[C:24](=[O:23])[O:25][CH2:26][CH2:27][C:28]=23)(=[O:12])=[O:11])[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[CH2:3][CH2:2]1Komponenten
3
Versuchsvorschrift
5-(2,3-Dihydro-indole-1-sulfonyl)-1,3-dihydro-indol-2-one was condensed with 4-oxo-2,4,6,7-tetrahydro-pyrano[3,4-c]pyrrole-1-carbaldehyde to give the title compound.
Quellen und Nachweise
- ORD-Eintrag
- ord-f39b0abf316d47a1b59ee23f1ae32962
- Quelldatensatz
- uspto-grants-2002_10